Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience

Akcam, A.; Ulku, A.; Rencuzogullari, A.; Eray, I.; Okoh, A.; Kuran, S.; Dalci, K.; Yalav, O.; Parsak, C.; Sakman, G.; Demiryurek, H.

doi:10.1016/j.transproceed.2015.04.018

Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience

Akcam A. T., Ulku A., Rencuzogullari A., Eray I. C., Okoh A., Kuran S., ...More

TRANSPLANTATION PROCEEDINGS, vol.47, no.5, pp.1445-1449, 2015 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 47 Issue: 5
Publication Date: 2015
Doi Number: 10.1016/j.transproceed.2015.04.018
Journal Name: TRANSPLANTATION PROCEEDINGS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1445-1449
Ankara University Affiliated: Yes

Abstract

Objectives. This study presents the overall long-term hepatitis B virus (HBV) recurrence rate with possible associated factors after hepatitis B immunoglobulin (HBIG) was given in combination with 4 different antiviral (lamivudine, adefovir, entecavir, and tenofovir) drugs.